Poon et al., 2008 - Google Patents
Association of corticotropin-releasing hormone receptor-2 genetic variants with acute bronchodilator response in asthmaPoon et al., 2008
View PDF- Document ID
- 11337296973434621150
- Author
- Poon A
- Tantisira K
- Litonjua A
- Lazarus R
- Xu J
- Lasky-Su J
- Lima J
- Irvin C
- Hanrahan J
- Lange C
- Weiss S
- Publication year
- Publication venue
- Pharmacogenetics and genomics
External Links
Snippet
Objective Corticotropin-releasing hormone receptor (CRHR)-2 participates in smooth muscle relaxation response and may influence acute airway bronchodilator response to short-acting β 2-agonist treatment of asthma. We aim to assess associations between …
- 230000004044 response 0 title abstract description 65
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Poon et al. | Association of corticotropin-releasing hormone receptor-2 genetic variants with acute bronchodilator response in asthma | |
| Hawkins et al. | The glucocorticoid receptor heterocomplex gene STIP1 is associated with improved lung function in asthmatic subjects treated with inhaled corticosteroids | |
| Day et al. | Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair | |
| Hand et al. | A novel locus for familial amyotrophic lateral sclerosis, on chromosome 18q | |
| Tantisira et al. | Genome-wide association identifies the T gene as a novel asthma pharmacogenetic locus | |
| Weiss et al. | Overview of the pharmacogenetics of asthma treatment | |
| Mandel et al. | The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA | |
| Drazen et al. | Heterogeneity of therapeutic responses in asthma | |
| Stefansson et al. | Neuregulin 1 and susceptibility to schizophrenia | |
| Keskin et al. | Genetic associations of the response to inhaled corticosteroids in asthma: a systematic review | |
| Tantisira et al. | Molecular properties and pharmacogenetics of a polymorphism of adenylyl cyclase type 9 in asthma: interaction between β-agonist and corticosteroid pathways | |
| Rajeevan et al. | Glucocorticoid receptor polymorphisms and haplotypes associated with chronic fatigue syndrome | |
| Ramsay et al. | Polymorphisms in the β2‐adrenoreceptor gene are associated with decreased airway responsiveness | |
| Machado et al. | Genetic association of the serotonin transporter in pulmonary arterial hypertension | |
| Turner et al. | β2 adrenoceptor Arg16Gly polymorphism, airway responsiveness, lung function and asthma in infants and children | |
| Ferri et al. | New clinical and molecular insights on Barth syndrome | |
| Kedda et al. | Characterization of two polymorphisms in the leukotriene C4 synthase gene in an Australian population of subjects with mild, moderate, and severe asthma | |
| Choudhry et al. | GSNO reductase and β2-adrenergic receptor gene–gene interaction: bronchodilator responsiveness to albuterol | |
| KR20160138071A (en) | Compositions and methods for the treatment and prevention of antipsychotic medication-induced weight gain | |
| Munthe‐Kaas et al. | Eosinophil cationic protein (ECP) polymorphisms and association with asthma, s‐ECP levels and related phenotypes | |
| Scaparrotta et al. | Role of THRB, ARG1, and ADRB2 genetic variants on bronchodilators response in asthmatic children | |
| Kim et al. | Peroxisome proliferator-activated receptor gamma coactivator 1 alpha promoter polymorphisms are associated with early-onset type 2 diabetes mellitus in the Korean population | |
| Litonjua et al. | Polymorphisms in signal transducer and activator of transcription 3 and lung function in asthma | |
| Rogers et al. | The interaction of glutathione S‐transferase M1‐null variants with tobacco smoke exposure and the development of childhood asthma | |
| Berberich et al. | Copy number variation in GCK in patients with maturity-onset diabetes of the young |